[Effect of corticosteroid therapy on the survival of patients with idiopathic dermatomyositis].
The 5- and 10-year survival rates of all 114 patients with primary DM were 89 and 81%, respectively. Significantly lower survival rates were noted in the patients receiving late and inadequate therapy. Corticosteroid therapy radically changed the outcome of DM, mainly due to early diagnosis and adequate therapy. A stable remission with preserved working ability was obtained in 40.4% of the patients, a complete cure of DM in 33.3%.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003882:Dermatomyositis / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis
D000305:Adrenal Cortex Hormones
Vliianie kortikosteroidnoĭ terapii na vyzhivaemost' bol'nykh idiopaticheskim dermatomiozitom.